
CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 1099141-1099455
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"T3676","span":{"begin":0,"end":314},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Ex vivo cultured LPS/IFNg-stimulated microglia display increased lytic activity against GL261 glioblastoma in vitro and in vivo Glioblastoma multiforme is the most common parenchymal brain tumour with an aggressive phenotype and a very poor prognosis even after treatment by surgery, radiation and/or chemotherapy."}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T97","span":{"begin":0,"end":314},"obj":"Sentence"}],"text":"Ex vivo cultured LPS/IFNg-stimulated microglia display increased lytic activity against GL261 glioblastoma in vitro and in vivo Glioblastoma multiforme is the most common parenchymal brain tumour with an aggressive phenotype and a very poor prognosis even after treatment by surgery, radiation and/or chemotherapy."}
CORD-19-PD-HP
{"project":"CORD-19-PD-HP","denotations":[{"id":"T265","span":{"begin":94,"end":106},"obj":"Phenotype"},{"id":"T266","span":{"begin":128,"end":151},"obj":"Phenotype"},{"id":"T267","span":{"begin":183,"end":195},"obj":"Phenotype"},{"id":"T268","span":{"begin":204,"end":214},"obj":"Phenotype"}],"attributes":[{"id":"A265","pred":"hp_id","subj":"T265","obj":"http://purl.obolibrary.org/obo/HP_0012174"},{"id":"A266","pred":"hp_id","subj":"T266","obj":"http://purl.obolibrary.org/obo/HP_0012174"},{"id":"A267","pred":"hp_id","subj":"T267","obj":"http://purl.obolibrary.org/obo/HP_0030692"},{"id":"A268","pred":"hp_id","subj":"T268","obj":"http://purl.obolibrary.org/obo/HP_0000718"}],"text":"Ex vivo cultured LPS/IFNg-stimulated microglia display increased lytic activity against GL261 glioblastoma in vitro and in vivo Glioblastoma multiforme is the most common parenchymal brain tumour with an aggressive phenotype and a very poor prognosis even after treatment by surgery, radiation and/or chemotherapy."}
CORD-19-PD-UBERON
{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T4512","span":{"begin":183,"end":188},"obj":"Body_part"}],"attributes":[{"id":"A4512","pred":"uberon_id","subj":"T4512","obj":"http://purl.obolibrary.org/obo/UBERON_0000955"}],"text":"Ex vivo cultured LPS/IFNg-stimulated microglia display increased lytic activity against GL261 glioblastoma in vitro and in vivo Glioblastoma multiforme is the most common parenchymal brain tumour with an aggressive phenotype and a very poor prognosis even after treatment by surgery, radiation and/or chemotherapy."}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T694","span":{"begin":94,"end":106},"obj":"Disease"},{"id":"T696","span":{"begin":128,"end":151},"obj":"Disease"},{"id":"T30138","span":{"begin":94,"end":106},"obj":"Disease"},{"id":"T37954","span":{"begin":128,"end":151},"obj":"Disease"}],"attributes":[{"id":"A694","pred":"mondo_id","subj":"T694","obj":"http://purl.obolibrary.org/obo/MONDO_0018177"},{"id":"A695","pred":"mondo_id","subj":"T694","obj":"http://purl.obolibrary.org/obo/MONDO_0020690"},{"id":"A696","pred":"mondo_id","subj":"T696","obj":"http://purl.obolibrary.org/obo/MONDO_0018177"},{"id":"A95278","pred":"mondo_id","subj":"T30138","obj":"http://purl.obolibrary.org/obo/MONDO_0018177"},{"id":"A27834","pred":"mondo_id","subj":"T30138","obj":"http://purl.obolibrary.org/obo/MONDO_0020690"},{"id":"A81379","pred":"mondo_id","subj":"T37954","obj":"http://purl.obolibrary.org/obo/MONDO_0018177"}],"text":"Ex vivo cultured LPS/IFNg-stimulated microglia display increased lytic activity against GL261 glioblastoma in vitro and in vivo Glioblastoma multiforme is the most common parenchymal brain tumour with an aggressive phenotype and a very poor prognosis even after treatment by surgery, radiation and/or chemotherapy."}